Overweight: Clinical Trials

1 trial for Overweight, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 suspended. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Suspended 1

Follow Overweight: new trials by email Literature Review of Overweight trials Research Report on Overweight

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Semaglutide to Reduce Atrial Fibrillation Burden
Semaglutide, Placebo - Atrial Fibrillation, Obesity
Phase 4SuspendedSan Francisco Veterans Affairs Medical Center1322023-05-012022-10-27

Narrower conditions

Atrial Fibrillation (1)  ·  Obesity (1)  ·  Weight Loss (1)

Broader conditions

Arrhythmias, Cardiac (1)  ·  Body Weight (1)  ·  Body Weight Changes (1)  ·  Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Overnutrition (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

semaglutide (1)

Sponsors

San Francisco Veterans Affairs Medical Center (1)

Countries

United States (1)